Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marcelo F Fernandes"'
Autor:
MATHEUS I.S. SANTOS, ÉRIKA C.T.A. BRANDÃO, EWERTON SANTOS, MARCUS VINÍCIUS A. BATISTA, CHARLES S. ESTEVAM, MARCELO R. ALEXANDRE, MARCELO F. FERNANDES
Publikováno v:
Anais da Academia Brasileira de Ciências, Vol 93, Iss suppl 4 (2021)
Abstract Pendimethalin herbicide is widely used and persists in the environment as a contaminant causing negative impacts, including for human health. Microorganisms have the capacity to remove many contaminants from the environment. Thus, the aim of
Externí odkaz:
https://doaj.org/article/d8b4aef1f1c4418e943321882cb47cda
Autor:
Salih N. Grevious, Marcelo F. Fernandes, Ama K. Annor, Michel Ibrahim, Garly R. Saint Croix, Eduardo de Marchena, Mauricio G. Cohen, Carlos E. Alfonso
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 12 (2020)
Background Right ventricular systolic dysfunction (RVSD) is a known risk factor for adverse outcome in surgical aortic valve replacement. Transcatheter aortic valve replacement (TAVR), on the other hand, has been shown to be either beneficial or have
Externí odkaz:
https://doaj.org/article/1ad42e2c4321452ca729b55a47a22968
Publikováno v:
European Heart Journal - Case Reports. 7
Background Intravenous leiomyomatosis (IVL) is a rare, benign smooth muscle cell tumour that extends beyond the pelvis. These tumours grow within vascular channels and can progress to involve the heart and pulmonary vasculature. Case Summary A 44-yea
Publikováno v:
Tópicos em microbiologia ISBN: 9786553672154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44983e2afdb0dfbfc7ef1de1c7992caf
https://doi.org/10.37423/221006719
https://doi.org/10.37423/221006719
Autor:
Laurence S. Sperling, Henry A. Liberman, Rhanderson Cardoso, Michael C. McDaniel, Marcelo F. Fernandes, Leonardo Knijnik, Abhinav Goyal, Manuel Rivera
Publikováno v:
The American journal of cardiology. 151
We aimed to evaluate if a shorter course of DAPT followed by P2Y12 inhibitor monotherapy is as effective as a 12-month course with fewer bleeding events. PubMed, Scopus, and Cochrane Central were searched for randomized controlled trials of ACS patie
Autor:
Carlos E. Alfonso, Mauricio G. Cohen, Eduardo de Marchena, Ama K. Annor, Michel Ibrahim, Salih N. Grevious, Garly Rushler Saint Croix, Marcelo F. Fernandes
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Right ventricular systolic dysfunction ( RVSD ) is a known risk factor for adverse outcome in surgical aortic valve replacement. Transcatheter aortic valve replacement ( TAVR ), on the other hand, has been shown to be either beneficial or